Literature DB >> 6191823

Pertussis: should we immunise neurologically disabled and developmentally delayed children?

R N Miles, G P Hosking.   

Abstract

A total of 400 children with neurological disorders were studied to ascertain whether they had been immunised against pertussis, the reasons for non-immunisation, and the "validity" of these reasons, as judged by interpretation of the recommendations of the Department of Health and Social Security. The results for this group were compared with those for a group of 400 aged matched controls. The study group had a significantly lower rate of immunisation than controls (p less than 0.01); rates for both groups fell sharply after 1975. A total of 192 study patients and 186 controls were not immunised. Those children with cerebral palsy had the lowest rate of immunisation (19%) and the highest number of valid reasons for non-immunisation (63%). Paediatricians apparently advised against immunisation in 61 (32%) of the index group but in only four (2%) of the controls. The risk of serious neurological handicap after pertussis immunisation is small and there is little evidence to support the view that underlying neurological disease predisposes a child to increased risk. The advice currently given by paediatricians may need to be reconsidered.

Entities:  

Mesh:

Year:  1983        PMID: 6191823      PMCID: PMC1548543          DOI: 10.1136/bmj.287.6388.318

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Pertussis vaccine--an analysis of benefits, risks and costs.

Authors:  J P Koplan; S C Schoenbaum; M C Weinstein; D W Fraser
Journal:  N Engl J Med       Date:  1979-10-25       Impact factor: 91.245

2.  Reactions to routine immunization in childhood.

Authors:  G Dick
Journal:  Proc R Soc Med       Date:  1974-05

3.  Neurological complications of pertussis inoculation.

Authors:  M Kulenkampff; J S Schwartzman; J Wilson
Journal:  Arch Dis Child       Date:  1974-01       Impact factor: 3.791

4.  Relation between vaccination and notification rates for whooping cough in England and Wales.

Authors:  R Pollard
Journal:  Lancet       Date:  1980-05-31       Impact factor: 79.321

5.  Evidence of whooping-cough-vaccine efficacy from the 1978 whooping-cough epidemic in Hertfordshire.

Authors:  M A Church
Journal:  Lancet       Date:  1979-07-28       Impact factor: 79.321

6.  Pertussis vaccination.

Authors:  A L Prensky
Journal:  Dev Med Child Neurol       Date:  1974-08       Impact factor: 5.449

7.  Benefits and risks of pertussis vaccine.

Authors:  G T Stewart
Journal:  N Engl J Med       Date:  1980-10-23       Impact factor: 91.245

8.  Pertussis immunisation and serious acute neurological illness in children.

Authors:  D L Miller; E M Ross; R Alderslade; M H Bellman; N S Rawson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

9.  Vaccination against whooping-cough. Efficacy versus risks.

Authors:  G T Stewart
Journal:  Lancet       Date:  1977-01-29       Impact factor: 79.321

10.  Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

Authors:  C L Cody; L J Baraff; J D Cherry; S M Marcy; C R Manclark
Journal:  Pediatrics       Date:  1981-11       Impact factor: 7.124

View more
  2 in total

Review 1.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Vaccine Coverage among Children with and without Intellectual Disabilities in the UK: Cross Sectional Study.

Authors:  Eric Emerson; Janet Robertson; Susannah Baines; Chris Hatton
Journal:  BMC Public Health       Date:  2019-06-13       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.